Metabolomic Biomarkers in Parkinson’s Disease

Yaping Shao, Xiaojiao Xu, Nanxing Wang, Guowang Xu, Weidong Le

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations


Metabolomics analysis has developed rapidly in recent decades and has become a powerful tool to understand comprehensive metabolic changes in biological systems. In Parkinson’s disease (PD) research, great efforts have been made toward the discovery of novel biomarkers and biochemical pathways to improve diagnosis, prognosis, and therapy. With the recent achievements in metabolomics, the identification of multiple novel biomarkers for PD has been greatly improved. In this chapter, we outline a detailed metabolomics workflow including sample pretreatment, instrumental analysis, and data interpretation and summarize recent advances in technology and bioinformatics implemented in metabolomics studies. Based on the current metabolomic findings in PD research, this chapter covers the most promising metabolic biomarkers and pathway disturbances in PD and discusses the progress made toward translating these findings to clinical practice, emphasizing the potential importance of endogenous small molecular metabolites in disease research.

Original languageEnglish (US)
Title of host publicationNeuromethods
PublisherHumana Press
Number of pages33
StatePublished - 2022

Publication series

ISSN (Print)0893-2336
ISSN (Electronic)1940-6045


  • Mass spectrometry
  • Metabolic biomarker
  • Metabolic disturbance
  • Metabolomics
  • Parkinson’s disease

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Psychiatry and Mental health


Dive into the research topics of 'Metabolomic Biomarkers in Parkinson’s Disease'. Together they form a unique fingerprint.

Cite this